ADE

Burzynski et al.

2015 Antineoplastons

A10 and AS2-1

N (%)

Chamberlain et al. [31]

2006

Cyclophosphamide

N (%)

Chamberlain et al. [32]

2008

CPT-11

N (%)

Yung et al. [22]

1999

Temozolomide

N (%)

Grade 3

Grade 4

Grade 3

Grade 4

Grades 3/4

Grade 5

Grades 3/4

Hypernatremia

5 (12.5)

2 (5)

Hypocalcemia

1 (2.5)

Hypokalemia

4(10)

2 (5)

Thrombocytopenia

5 (12)

1 (2)

2 (5)

10 (6)

Neutropenia

7 (17)

1 (2)

1 (2)

3 (2)

Leukopenia

15 (37)

2 (5)

1 (2)

3 (2)

Anemia

5 (12)

1 (1)

Asthenia

2 (5)

9 (6)

Fatigue

1 (2.5)

9 (22)

7 (5)

Fever

3 (2)

Peripheral edema

1 (1)

Weight loss

Headache

1 (2)

10 (6)

Convulsions

1 (2)

8 (5)

Dizziness

1 (1)

Somnolence

1 (2.5)

5 (3)

Suicide attempt

Pain

1 (2.5)

Other neurological ADE*

2 (1)

Hypertension

Syncope

Bradycardia

Apnea

Anorexia

1 (1)

Constipation

1(2)

1 (1)

Diarrhea

3 (7)

1 (2)

3 (2)

Nausea

3 (7)

2 (5)

16 (10)

Vomiting

2 (5)

4 (10)

10 (6)

Pruritus

2 (1)

Infection

1 (2)

1 (2)

Thrombophlebitis

1 (2)

1 (2)

Intracranial hemorrhage

Bilirubinemia

Hyperglycemia

Urinary frequency

1 (2.5)

Urticaria

1 (2.5)

Basal cell carcinoma